Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009
- PMID: 20197216
- DOI: 10.1016/j.drugalcdep.2010.02.001
Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009
Abstract
Background: North America is the region with the world's highest prescription opioid (PO) use. Non-medical use of prescription opioids and PO-related morbidity and mortality have strongly increased in the US in recent years. It is assumed that similar trends are occurring in Canada, but there is less empirical evidence to support this. Treatment demand for problematic PO use is an important indicator of PO-related morbidity.
Methods: Levels and changes related to the caseload of PO-related treatment admissions were assessed using system-level data from the Drug and Alcohol Treatment Information System (DATIS), the reporting system for publicly funded addiction treatment services in the province of Ontario (Canada) for the period April 2004-March 2009 (n=500,217). In addition, basic socio-demographic and clinical characteristics of PO-related treatment admissions in the final year of study (n=10,125) were examined.
Results: The number of PO-related treatment admissions in DATIS rose by 60%, and their prevalence in the total caseload increased from 9.4% to 15.7% in the study period. Three-quarters of PO-clients reported other problem substances; the most common co-occurring problem substance was cocaine/crack. The majority of PO-clients were <35 years of age, unemployed, and referred to treatment by others.
Interpretation: Demand for treatment for problematic PO use has risen substantially in Ontario in the past five years in the wider context of substantially increased overall PO use and related harms in Canada. The interaction dynamics between these different indicators need to be systematically examined and monitored as the basis for evidence-based interventions.
Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Reductions in non-medical prescription opioid use among adults in Ontario, Canada: are recent policy interventions working?Subst Abuse Treat Prev Policy. 2013 Feb 14;8:7. doi: 10.1186/1747-597X-8-7. Subst Abuse Treat Prev Policy. 2013. PMID: 23406368 Free PMC article.
-
Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.Int J Drug Policy. 2009 Jan;20(1):90-2. doi: 10.1016/j.drugpo.2008.02.016. Epub 2008 Jun 3. Int J Drug Policy. 2009. PMID: 18508256
-
Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada.Drug Alcohol Depend. 2012 Jul 1;124(1-2):172-6. doi: 10.1016/j.drugalcdep.2011.12.014. Epub 2012 Jan 20. Drug Alcohol Depend. 2012. PMID: 22265193
-
National drug control policy and prescription drug abuse: facts and fallacies.Pain Physician. 2007 May;10(3):399-424. Pain Physician. 2007. PMID: 17525776 Review.
-
Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?Addiction. 2014 Feb;109(2):177-81. doi: 10.1111/add.12224. Epub 2013 May 20. Addiction. 2014. PMID: 23692335 Review.
Cited by
-
Initiation into prescription opioid injection and associated trends in heroin use among people who use illicit drugs.Drug Alcohol Depend. 2016 Dec 1;169:73-79. doi: 10.1016/j.drugalcdep.2016.10.017. Epub 2016 Oct 20. Drug Alcohol Depend. 2016. PMID: 27780105 Free PMC article.
-
Effect of a course-based intervention and effect of medical regulation on physicians' opioid prescribing.Can Fam Physician. 2013 May;59(5):e231-9. Can Fam Physician. 2013. PMID: 23673603 Free PMC article.
-
Systematic assessment of opioid advertisements in general medical journals.Can Fam Physician. 2023 Mar;69(3):192-197. doi: 10.46747/cfp.6903192. Can Fam Physician. 2023. PMID: 36944508 Free PMC article.
-
The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample.Am J Addict. 2014 Jul-Aug;23(4):343-8. doi: 10.1111/j.1521-0391.2013.12105.x. Epub 2013 Sep 24. Am J Addict. 2014. PMID: 24112096 Free PMC article. Clinical Trial.
-
Reductions in non-medical prescription opioid use among adults in Ontario, Canada: are recent policy interventions working?Subst Abuse Treat Prev Policy. 2013 Feb 14;8:7. doi: 10.1186/1747-597X-8-7. Subst Abuse Treat Prev Policy. 2013. PMID: 23406368 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous